Live from the NIH registry
Studies recruiting near Gainesville right now
Top 25 of 149 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Duluth, GA Investigative Site 10083 — Duluth, Georgia (26.8 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50566 — Gainesville, Georgia (0.6 mi)
· Sponsor: UCB Biopharma SRL
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Eli Lilly and Company
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Schizophrenia, Bipolar Disorder
Phase 3
Interventional 300 participants sought
Salveo Integrative Health Inc — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
ProCare Prosthetics x Ottobock.care — Buford, Georgia (15.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 2
Interventional 60 participants sought
Investigator Site # 1 — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Akebia Therapeutics
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Physicians Research Associates LLC — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Zucara Therapeutics Inc.
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Narcolepsy Type 1
Phase 2, Phase 3
Interventional 500 participants sought
Georgia Neuro Center — Gainesville, Georgia (0.6 mi)
· Sponsor: Takeda
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Northside Hospital - Gwinnett — Lawrenceville, Georgia (24.8 mi)
· Sponsor: NRG Oncology
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
NSC Research Inc — Johns Creek, Georgia (27.8 mi)
· Sponsor: Boehringer Ingelheim
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Suwanee, Georgia (21.5 mi)
· Sponsor: AstraZeneca
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Hoffmann-La Roche
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
North Georgia Health System — Gainesville, Georgia (0.6 mi)
· Sponsor: Adela, Inc
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Northeast Georgia Medical Ctr — Gainesville, Georgia (0.6 mi)
· Sponsor: Novo Nordisk A/S
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Parris and Associates Rheumatology — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: SWOG Cancer Research Network
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
One Health Research Clinic Inc. — Johns Creek, Georgia (27.8 mi)
· Sponsor: pH-D Feminine Health LLC
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Teak Research Consults — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Eli Lilly and Company
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
N/A
Observational 5,000 participants sought
Northeast Georgia Medical Center — Gainesville, Georgia (0.6 mi)
· Sponsor: HistoSonics, Inc.
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 630 participants sought
Research Site — Gainesville, Georgia (0.6 mi)
· Sponsor: AstraZeneca
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Northside Hospital - Gwinnett — Lawrenceville, Georgia (24.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
NSC Research Inc — Johns Creek, Georgia (27.8 mi)
· Sponsor: Boehringer Ingelheim
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Georgia Nephrology — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
Acute Kidney Injury
N/A
Interventional 339 participants sought
Northeast Georgia Health System — Gainesville, Georgia (0.6 mi)
· Sponsor: SeaStar Medical